Glycosaminoglycans and protein disulfide isomerase-mediated reduction of HIV Env

Molecular Pharmacology

Volumn 67, Issue 4, 2005, Pages 1111-1118

  Barbouche, Rym ^a   Lortat Jacob, Hugues ^b   Jones, Ian M ^c   Fenouillet, Emmanuel ^a  

^a CNRS   (France)

^b INSTITUT DE BIOLOGIE STRUCTURALE   (France)

^c UNIVERSITY OF READING   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVIRUS AGENT; CD4 ANTIGEN; GLYCOPROTEIN GP 120; GLYCOPROTEIN GP 41; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; HEPARIN; LYMPHOCYTE MEMBRANE RECEPTOR; MERCAPTOETHANOL; PROTEIN DISULFIDE ISOMERASE; SODIUM CHLORATE; THIOL DERIVATIVE; VIRUS ENVELOPE PROTEIN;

ANTIVIRAL ACTIVITY; ARTICLE; CELL SURFACE; CONFORMATIONAL TRANSITION; CONTROLLED STUDY; DISULFIDE BOND; GLYCOSAMINOGLYCAN METABOLISM; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; IN VITRO STUDY; MEMBRANE FUSION; OXIDATION REDUCTION REACTION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; SURFACE PLASMON RESONANCE;

DISULFIDES; GLYCOSAMINOGLYCANS; HIV ENVELOPE PROTEIN GP120; HUMANS; LYMPHOCYTES; OXIDATION-REDUCTION; PROTEIN DISULFIDE-ISOMERASE; RECEPTORS, CXCR4;

EID: 15744397194     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.104.008276     Document Type: Article

References (35)

1. Barbouche R, Miquelis R, Jones IM, and Fenouillet E (2003) Protein disulfide isomerase-mediated reduction of two disulfide bonds of HIV Env gp120 occurs post CXCR4 binding and is required for fusion. J Biol Chem 278:3131-3136.
2. Batinic D and Robey FA (1992) The V3 region of the envelope glycoprotein of human immunodeficiency virus type 1 binds sulfated polysaccharides and CD4-derived synthetic peptides. J Biol Chem 267:6664-6671.
3. Berger EA, Murphy PM, and Farber JM (1999) Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism and disease. Annu Rev Immunol 17:657-700.
4. Calatroni A, Vinci R, and Ferlazzo AM (1992) Characteristics of the interactions between acid glycosaminoglycans and proteins in normal human plasma as revealed by the behaviour of the protein-polysaccharide complexes in ultrafiltration and Chromatographic procedures. Clin Chim Acta 206:167-180.
5. Doms RW and Peiper SC (1997) Unwelcomed guests with master keys: how HIV uses chemokine receptors for cellular entry. Virology 235:179-190.
6. Droge W (2002) The plasma redox state and ageing. Ageing Res Rev 1:257-278.
7. Einfeld D (1996) Maturation and assembly of retroviral glycoproteins. Curr Top Microbiol Immunol 214:133-176.
8. Fenouillet E, Barbouche R, Courageot J, and Miquelis R (2001) The catalytic activity of protein disulfide isomerase is involved in human immunodeficiency virus envelope-mediated membrane fusion after CD4 cell binding. J Infect Dis 183:744-752.
9. Fenouillet E, Barbouche R, and Jones IM (2004) HIV Env reduction post-receptor binding, a new target for AIDS treatment. Blood 104:296.
10. Ferrari DM and Soling HD (1999) The protein disulphide-isomerase family: unravelling a string of folds. Biochem J 338:1-10.
11. Gallina A, Hanley TM, Mandel R, Trahey M, Broder CC, Viglianti GA, and Ryser HJ (2002) Inhibitors of protein-disulfide isomerase prevent cleavage of disulfide bonds in receptor-bound glycoprotein 120 and prevent HIV-1 entry. J Biol Chem 277: 50579-50588.
12. Gupta-Bansal R, Frederickson RCA, and Branden KR (1995) Proteoglycan-mediated inhibition of Aβ proteolysis: a potential cause of senile plaque accumulation. J Biol Chem 270:18666-18671.
13. Harrop HA, Coombe DR, and Rider CC (1994) Heparin specifically inhibits binding of V3 loop antibodies to HIV-1 gp120, an effect potentiated by CD4 binding. AIDS 8:183-192.
14. Harrop HA and Rider CC (1998) Heparin and its derivatives bind to HIV-1 recombinant envelope glycoproteins, rather than to recombinant HIV-1 receptor, CD4. Glycobiology 8:131-137.
15. Ito M, Baba M, Sato A, Pauwels R, de Clercq E, and Shigeta S (1987) Inhibitory effect of dextran sulfate and heparin on the replication of human immunodeficiency virus (HIV) in vitro. Antivir Res 7:361-367.
16. Jolly C, Kashefi K, Hollinshead M, and Sattentau QJ (2004) HIV-1 cell to cell transfer across an Env-induced, actin-dependent synapse. J Exp Med 198:283-293.
17. Lawrence DA, Song R, and Weber P (1996) Surface thiols of human lymphocytes and their changes after in vitro and in vivo activation. J Leukoc Biol 60:611-618.
18. Leonard C, Spellman MW, Riddle L, Harris R, Thomas J, and Gregory TJ (1990) Assignment of intrachain disulfide bonds and characterization of potential glycosylation sites of the type 1 recombinant human immunodeficiency virus envelope glycoprotein (gp120) expressed in Chinese hamster ovary cells. J Biol Chem 265:10373-10382.
19. Mandel R, Ryser HJ, Ghani F, Wu M, and Peak D (1993) Inhibition of a reductive function of the plasma membrane by bacitracin and antibodies against protein disulfide-isomerase. Proc Natl Acad Sci USA 90:4112-4116.
20. Markovic I, Stantchev TS, Fields KH, Tiffany LJ, Tomic M, Weiss CD, Broder CC, Strebel K, and Clouse KA (2004) Thiol/disulfide exchange is a prerequisite for CXCR4-tropic HIV-1 envelope-mediated T-cell fusion during viral entry. Blood 103:1586-1594.
21. Mondor I, Ugolini S, and Sattentau QJ (1998) Human immunodeficiency virus type 1 attachment to HeLa CD4 cells is CD4-independent and gp120 dependent and requires cell surface heparans. J Virol 72:3623-3634.
22. Moulard M, Lortat-Jacob H, Mondor I, Roca G, Wyatt R, Sodroski J, Zhao J, Olson W, Kwong PD, and Sattentau QJ (2000) Selective interactions of polyanions with basic surfaces on human immunodeficiency virus type 1 gp120. J Virol 74:1948-1960.
23. Ohshiro Y, Murakami T, Matsuda K, Nishioka K, Yoshida K, and Yamamoto N (1996) Role of cell surface glycosaminoglycans of human T cells in human immunodeficiency virus type 1 (HIV-1) infection. Microbiol Immunol 40:827-835.
24. Patel M, Yanagishita M, Roderiquez G, Bou-Habib DC, Oravecz T, Hascall VC, and Norcross MA (1993) Cell-surface heparan sulfate proteoglycan mediates HIV-1 infection of T-cell lines. AIDS Res Hum Retrovir 9:167-174.
25. Pierson TC, Doms RW, and Pohlmann S (2004) Prospects of HIV-1 entry inhibitors as novel therapeutics. Rev Med Virol 14:255-270.
26. Rider CC (1997) The potential for heparin and its derivatives in the therapy and prevention of HIV-1 infection. Glycoconj J 14:639-642.
27. Roderiquez G, Oravecz T, Yanagishita M, Bou-Habib DC, Mostowski H, and Norcross MA (1995) Mediation of human immunodeficiency virus type 1 binding by interaction of cell surface heparan sulfate proteoglycans with the V3 region of envelope gp120-gp41. J Virol 69:2233-2239.
28. Ryser HJ, Levy EM, Mandel R, and DiSciullo GJ (1994) Inhibition of human immunodeficiency virus infection by agents that interfere with thiol-disulfide interchange upon virus-receptor interaction. Proc Natl Acad Sci USA 91:4559-4563.
29. Ryser HJ, Mandel R, and Ghani F (1991) Cell surface sulfhydryls are required for the cytotoxicity of diphtheria toxin but not of ricin in Chinese hamster ovary cells. J Biol Chem 266:18439-18442.
30. Sadir R, Baleux F, Grosdidier A, Imberty A, and Lortat-Jacob H (2001) Characterization of the stromal cell-derived factor-1a/heparin complex. J Biol Chem 276: 8288-8296.
31. Sadir R, Imberty A, Baleux F, and Lortat-Jacob H (2004) Heparan sulfate/heparin oligosaccharides protect stromal cell-derived factor-1 (SDF-1)/CXCL12 against proteolysis induced by CD26/dipeptidyl peptidase IV. J Biol Chem 279:43854-43860.
32. Sahaf B, Heydari K, Herzenberg LA, and Herzenberg LA (2003) Lymphocyte surface thiol levels. Proc Natl Acad Sci USA 100:4001-4005.
33. Saksela O, Moscatelli D, Sommer A, and Rifkin DB (1988) Endothelial cell-derived heparan sulfate binds basic fibroblast growth factor and protects it from proteolytic degradation. J Cell Biol 107:743-751.
34. Ugolini S, Mondor I, and Sattentau QJ (1999) HIV-1 attachment: another look. Trends Microbiol 7:144-149.
35. Zhang YJ, Hatziioannou T, Zang T, Braaten D, Luban J, Goff SP, and Bieniasz PD (2002) Envelope-dependent, cyclophilin-independent effects of glycosaminoglycans on human immunodeficiency virus type-1 attachment and infection. J Virol 76: 6332-6343.